Thrombolytic therapy in coronary thrombosis.

[Thrombolytic therapy in prosthetic valve thrombosis].

Thrombolytic Therapy for Cerebral Vein Thrombosis in Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus

A 20-year-old woman was admitted to a Gynecology Hospital in her 6th month of pregnancy for high blood pressure and tonic-clonic seizure. Primary diagnosis was eclampsia, and for that reason she underwent cesarean section. She also had headache on frontal and parietal areas without nausea or vomiting. There was not a focal neurological sign. Rheumatology consultation was requested. Systemic lup...

Review Article Thrombolytic therapy in Cerebral Venous Sinus Thrombosis

The use of thrombolytic agents to rapidly lyse the clot has emerged as a therapeutic modality, in concert with interventional neuroradiologic approaches to deliver the agent locally at the site of thrombosis.There are no randomized, double blind, placebo, controlled trials to support thrombolysis as a first line therapy in patients with cerebral venous sinus thrombosis compared to standard ther...

Direct thrombolytic therapy in portal and mesenteric vein thrombosis.

A 34-year-old female from Laos presented to the emergency department with a 3-week history of worsening abdominal pain; she subsequently developed an acute abdomen requiring emergent exploratory laparotomy. An intraoperative angiography was performed, which revealed complete portal vein thrombosis. A 5F 20-cm infusion catheter was placed through an omental vein, and tissue plasminogen activator...

Thrombolytic Therapy in Thrombosis NATIONAL INSTITUTES OF HEALTH

A NATIONAL INSTITUTES OF HEALTH Consensus Development Conference, held at NIH April 10-12, 1980, addressed the issue of thrombolytic therapy* for the management of acute deep-vein thrombosis and pulmonary embolism. At NIH, consensus development conferences bring together biomedical research scientists, practicing physicians, consumers, and others as appropriate in an effort to reach general agr...